Treats cerebral folate transport deficiency. ANDA 72733, held by Hikma. Leucovorin Calcium.
As of Nov 16, 2026, ANDA 72733 (Leucovorin Calcium), held by Hikma, was first approved by FDA on Feb 22, 1993, with 8 approved supplements and 0 published complete response letters.
Leucovorin is a folate analog indicated:
| Date | Submission | Status | Documents |
|---|---|---|---|
| Feb 22, 1993 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Leucovorin CalciumEQ 5MG BASE · tablet;oral | Leucovorin Calcium | Rx |
| May 5, 2026 | Supplement 11Labeling · Standard review | Approved | None posted |
| Nov 7, 2001 | Supplement 7Manufacturing | Approved | None posted |
| Oct 22, 2001 | Supplement 6Manufacturing | Approved | None posted |
| Nov 7, 1997 | Supplement 5Labeling | Approved | None posted |
| Aug 28, 1996 | Supplement 4Manufacturing | Approved | None posted |
| Nov 4, 1994 | Supplement 3Manufacturing | Approved | None posted |
| Nov 4, 1994 | Supplement 2Labeling | Approved | None posted |
| Nov 4, 1994 | Supplement 1Manufacturing | Approved | None posted |
| Feb 22, 1993 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters